OSUMI, H., MATSUSAKA, S., WAKATSUKI, T., SUENAGA, M., SHINOZAKI, E., & MIZUNUMA, N. (2015). Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients. Mol Clin Oncol.
Citação norma ChicagoOSUMI, HIROKI, SATOSHI MATSUSAKA, TAKERU WAKATSUKI, MITSUKUNI SUENAGA, EIIJ SHINOZAKI, and NOBUYUKI MIZUNUMA. "Angiotensin II Type-1 Receptor Blockers Enhance the Effects of Bevacizumab-based Chemotherapy in Metastatic Colorectal Cancer Patients." Mol Clin Oncol 2015.
MLA引文OSUMI, HIROKI, et al. "Angiotensin II Type-1 Receptor Blockers Enhance the Effects of Bevacizumab-based Chemotherapy in Metastatic Colorectal Cancer Patients." Mol Clin Oncol 2015.
警告:這些引文格式不一定是100%准確.